Mesco Pharmaceuticals: Board Meeting Intimation for Board Meeting Intimation For Consider And Approve The Standalone Unaudited Financial Results For The Quarter Ended On 30Th September 2021 Along With Limited Review Reports

MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 inter alia to consider and approve The standalone unaudited financial results for the quarter ended on 30th September 2021 along with Limited Review Reports.